Results 201 to 210 of about 1,500,479 (319)

Risk‐aware safe reinforcement learning for control of stochastic linear systems

open access: yesAsian Journal of Control, EarlyView.
Abstract This paper presents a risk‐aware safe reinforcement learning (RL) control design for stochastic discrete‐time linear systems. Rather than using a safety certifier to myopically intervene with the RL controller, a risk‐informed safe controller is also learned besides the RL controller, and the RL and safe controllers are combined together ...
Babak Esmaeili   +2 more
wiley   +1 more source

10. Macroeconomic Factors and Inequities in Youth Violence

open access: yes, 2020
Jennifer L. Matjasko   +2 more
openaire   +1 more source

NEWSROOM DIVERSITY AND ITS CONTRIBUTION TO REDUCED INEQUALITIES (SDG 10)

open access: hybrid
Ibragimova Poshshajon   +3 more
openalex   +2 more sources

Interval‐valued Caputo–Fabrizio fractional derivative in continuous programming

open access: yesAsian Journal of Control, EarlyView.
Abstract This study investigates a novel class of variational programming problems characterized by fractional interval values, formulated under the Caputo–Fabrizio fractional derivative with an exponential kernel. Invex and generalized invex functions are used to discuss the Mond–Weir‐type dual problem for the considered variational problem.
Krishna Kummari   +2 more
wiley   +1 more source

Modeling and parameter estimation for fractional large‐scale interconnected Hammerstein systems

open access: yesAsian Journal of Control, EarlyView.
Abstract This paper addresses the challenge of modeling and identifying large‐scale interconnected systems exhibiting memory effects, hereditary properties, and non‐local interactions. We propose a fractional‐order extension of the Hammerstein architecture that incorporates Grünwald–Letnikov operators to capture complex dynamics through multiple ...
Mourad Elloumi   +2 more
wiley   +1 more source

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence for regulatory science and innovation in pharmacogenomics (CERSI‐PGx)

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo   +22 more
wiley   +1 more source

Home - About - Disclaimer - Privacy